Discover 1,123 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Alabama provides a diverse range of research opportunities for healthy volunteers and individuals with specific health conditions. Leading research centers in Birmingham, Montgomery, and Mobile are seeking participants, offering access to innovative treatments and cutting-edge medical care.
Filter
1
Filter results
Results: 1,123
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
for
Hypertension (HTN)
Location: Berlin NJ, Linwood PA, Baltimore MD, Lanham MD,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07543120
Phase 2, Recruiting
The Effect of Spinal Cord Stimulators on Restless Leg Syndrome
for
Restless Leg Syndrome (RLS), Spinal Cord Stimulation (SCS)
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT07179406
Recruiting
Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial
for
Prematurity
Location: Birmingham AL, Houston TX, Dallas TX
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 0
Code: NCT06420531
Recruiting
Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention
for
HIV Seropositivity
Location: Huntsville AL, Birmingham AL, Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18 - 49
Code: NCT05723653
Recruiting
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
for
Rhinovirus Infection
Location: Brooklyn NY, Hamilton NJ, Binghamton NY, Lutherville MD,
Sponsor: Altesa Biosciences, Inc.
Sex: All
Age: 40 - 70+
Code: NCT07610395
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Menopausal HT for Women Living With HIV (HoT)
for
HIV Infection, Menopause
Location: Boston MA, New York NY, Newark NJ, Philadelphia PA,
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Sex: Female
Age: 40 - 60
Code: NCT06856174
Recruiting
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
for
Phelan-McDermid Syndrome
Location: Brookline MA, Lexington MA, New York NY, Chevy Chase MD,
Sponsor: Neuren Pharmaceuticals Limited
Sex: All
Age: 3 - 12
Code: NCT07593391
Phase 3, Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
for
Core Binding Factor Acute Myeloid Leukemia
Location: Boston MA, Providence RI, The Bronx NY, Wilkes-Barre PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT06917911
Phase 2, Recruiting
Video Inspired Discussions About Ethical Outcomes in Pediatrics
for
Pediatric Cancer
Location: Boston MA, Atlanta GA, Birmingham AL
Sponsor: Massachusetts General Hospital
Sex: All
Age: 0+
Code: NCT06786104
Recruiting
How Osteopathic Treatment Affects the Leg and Foot in People With Low Back Pain
for
Chronic Low Back Pain (CLBP)
Location: Auburn AL
Sponsor: Edward Via Virginia College of Osteopathic Medicine
Sex: All
Age: 18 - 65
Code: NCT07193212
Recruiting
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
for
Acute Myeloid Leukaemia (AML)
Location: Providence RI, Morristown NJ, Philadelphia PA, Miami FL,
Sponsor: Moleculin Biotech, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06788756
Phase 2, Phase 3, Recruiting
DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC
for
Non Small Cell Lung Cancer
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT06364917
Phase 2, Recruiting
Treatment of Antibody-Mediated Rejection (ABMR) With CarBel
for
Kidney Transplant Rejection
Location: New York NY, Durham NC, Cleveland OH, Cincinnati OH,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70+
Code: NCT06918990
Phase 1, Recruiting
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive